Symptomatic slow acting drugs for osteoarthritis (SYSADOA)

1. Jordan KM, Arden NK, Doherty M et al.: EULAR recommendations 2003: an evidence based approach to the management of the knee osteoarthritis: Report of a task force of the Standing Comittee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.

2. Zhang W, Doherty M, Arden N et al.: EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Comittee for Internationl Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–81.

3. Zhang W, Doherty M, Leeb BF et al.: EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66(3): 377–88.

4. Zhang W, Moskowitz RW, Nuki G et al.: OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007; 15(9): 981–1000.

5. Zhang W, Moskowitz RW, Nuki G et al.: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence–based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16(2): 137–62.

6. Zhang W, Nuki G, Moskowitz RW et al.: OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010; 18(4): 476–99.

7. Hochberg MC, Altman RD, Toupin April K et al.: American College of Rheumatology 2012 Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012; 64: 465–74.

8. Pavelka K. Doporučení České revmatologické společnosti pro terapii osteoartrózy. Čes Revmatol 2012; 20: 95–114.

9. Reginster JY, Deroisy R, Rovati LC et al.: Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo–controlled clinical trial. Lancet 2001 Jan 27; 357: 251–6.

10. Pavelka K, Gatterová J, Olejárová M et al.: Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113–23.

11. Uebelhart D, Malaise M, Marcolongo R et al.: Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 2004; 12: 269–76.

12. Verbruggen G, Goemaere S, Veys EM: Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol 2002; 21: 231–43.

13. Michel BA, Stucki G, Frey D et al.: Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 2005; 52: 779–86.

14. Rintelen B, Neumann K, Leeb BF: A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 2006; 166: 1899–906.

15. Dougados M, Nguyen M, Berdah L et al.: ECHODIAH Investigators Study Group. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001; 44: 2539–47.

16. Christensen P, Bartels EM, Astrup A et al.: Symptomatic efficacy of avocado-soybeans unsaponifiables (ASU) in OA patients: a metaanalysis of randomized, controlled trials. Osteoarthritis Cartilage 2008; 16(4): 399–408.

17. Lo GH, LaValley M, McAlindon T, Nelson DT: Intra–articular hyaluronic acid in the treatment of knee osteoarthritis. JAMA 2003; 290: 3115–21.

18. Wang CH, Lin J, Chang CH et al.: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. J Bone Point Surg 2004; 86: 538–45.

19. Modawal A, Ferrer M, Choi HK, Castle JA: Hyaluronic acid injections relieve knee pain. J Fam Pract 2005; 54: 758–67.

20. Bellamy N, Campbell J, Robinson V et al.: Viscosuplementation for the treatment of osteoarthritis of the knee. The Cochrane Database of Systemic Reviews 2006, Issue 3. Art No.: CD005321.pub2. DOI 10.1002/14651858.CD005321.pub2

21. Clegg D: Effects of glucosamine, chondroitin sulfate and the two in combination in painful knee osteoarthritis. New Eng J Med 2006; 354: 795–807.

22. Wildi LM, Raynauld JP, Martel-Pelletier J et al.: Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011; 70(6): 982–9.

23. Singh K, Sharma R, Rai J. Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee. Int J Rheum Dis 2012; 15(1): 69–77.

24. Strand V, Baraf HS, Lavin PT et al.: A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2012; 20(5): 350–6.

25. Pavelka K, Uebelhart D: Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial^®) vs hylan G–F20 (Synvisc^®) in the treatment of symptomatic knee osteoarthritis. A double–blind, controlled, randomized, parallel-group non-inferiority study. Osteoarthritis Cartilage 2011; 19(11): 1294–300.

26. Navarro–Sarabia F, Coronel P, Collantes E et al.: AMELIA study group. A 40-month multicentre, randomised placebo–controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis 2011; 70(11): 1957–62.

27. DeGroot H 3rd, Uzunishvili S, Weir R et al.: Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am 2012 Jan 4; 94(1): 2–8.